Brush Away Your Sniffles With New Allergy-Fighting Toothpaste

iStock
iStock

For people with severe allergies, relief can cost a lot of time. Doctors can administer allergy shots, but you need them regularly, as often as multiple times a week. If you don’t complete the proper regimen, which can last for years, the treatment won’t be effective. Popular Science reports that there’s a new method for administering long-term allergy medicine that could prove a whole lot more convenient for patients, and it doesn’t involve any needles. It’s toothpaste.

Allerdent is a specially formulated toothpaste that can be customized to treat particular allergies. Typical allergy shots contain very small amounts of the allergen you’re trying to desensitize your body to—much like a vaccine contains the microbe of the disease it’s designed to inoculate you against. With Allerdent, instead of putting that allergen extract in a shot, the doctor mixes it into a toothpaste base. Patients can take that toothpaste home and use it daily, rather than coming in for a weekly allergy shot.

It’s not the first mouth-based allergy medicine. There are also under-the-tongue allergy drops that are widely used in Europe, but they can irritate the stomach and throat if you accidentally swallow them. But since the mucus membrane of the mouth has a high immune response (to protect against all the weird stuff you put in your mouth every day), it’s a great place to administer allergy medicine. Allergy toothpaste similarly allows you to put the medicine where it’s most effective, but it doesn't involve holding a squirt of oil in your mouth, and it doesn't have any gastrointestinal side effects.

The toothpaste comes with a pre-measured pump so that you get exactly the amount of medicine you need (no need to eyeball what the size of a pea is) and it can remain effective with up to 10 allergen extracts, so you could treat multiple allergies at one time. It could be especially effective to treat kids, since they're more likely to have trouble with shots or under-the-tongue drops. And, because it's something you can do at home, patients are more likely to stick to the regimen.

Allerdent isn’t easy to obtain at the moment. Your doctor has to order it, and because the FDA hasn’t approved allergen extracts in toothpaste (they’re only approved in shot form), your insurance company might not pay for it. As research into Allerdent and other oral allergy medicines progresses, though, the product might become easier to access.

[h/t Popular Science]

FDA Recalls Thyroid Medications Due to Contamination Risk

iStock
iStock

Hypothyroid medications manufactured by Westminster Pharmaceuticals have been recalled after it was discovered that one of the company’s Chinese suppliers failed to meet U.S. Food and Drug Administration (FDA) standards, CNN reports.

The oral tablets contain levothyroxine (LT4) and liothyronine (LT3), which are both synthetic hormones used to treat thyroid conditions.

The medicine was recalled as a precaution after it was discovered during a 2017 FDA inspection that the Chinese supplier in question, Sichuan Friendly Pharmaceutical Co., was not practicing good manufacturing practices.

However, patients with serious thyroid conditions shouldn’t throw out their pills just yet. No adverse effects from the medication have been reported, and the risk of not taking the medication outweighs the risk of taking a recalled pill.

According to the FDA, “Because these products may be used in the treatment of serious medical conditions, patients taking the recalled medicines should continue taking their medicine until they have a replacement product.”

For more information on the specific lots and products in question, visit the FDA’s website.

[h/t CNN]

The First Generic EpiPen Just Received FDA Approval

iStock
iStock

For people with severe allergies, having an EpiPen on hand could mean the difference between life and death. But that safety net comes at a high price: In the past decade, the cost of the brand-name drug has risen by more than 400 percent, with a set of two pens selling for $600. Now, CNBC reports that patients can finally get the treatment they need for a more reasonable amount of cash: The FDA has approved a generic version of Mylan's EpiPen, making it the first direct generic competitor to the brand-name medication.

Teva Pharmaceutical's versions of both the EpiPen and EpiPen Jr. will work like the originals, with an injector delivering epinephrine, a chemical that opens the airways, into the bloodstream of someone suffering an allergic reaction. Similar generics have been made commercially available in the past: In 2016, Mylan introduced a cheaper version of its own product at $300 for a two-pack, and in 2017 CVS started selling an EpiPen alternative for $110. Teva's drug is different, though. It's a direct generic copy of the EpiPen, which means pharmacists will be free to offer it to patients who have been prescribed Mylan's product. A price hasn't been announced, but Teva's EpiPen could end up being significantly cheaper than Mylan's generic EpiPen, which could in turn bring down prices of the injector drug across the board.

The exorbitant price of the EpiPen has hit patients hard in recent years. Some EMTs have even started loading epinephrine into syringes manually rather than paying for the drug-injector combo. Though the drug itself isn't protected by a patent, the design of the EpiPen device is difficult for competing pharmaceutical companies to replicate, which has allowed Mylan to charge whatever it can for the product.

In 2017, the FDA tweaked its guidelines to make it easier for generic EpiPen competitors to receive market approval, even if the design of the new injector differed slightly from the original. With the approval of Teva's auto-injector made official, more EpiPen generics could soon start appearing behind pharmacy counters.

[h/t CNBC]

SECTIONS

arrow
LIVE SMARTER
More from mental floss studios